Applied Therapeutics股票讨论区

$Applied Therapeutics(APLT.US)$ Applied Therapeutics Plans To Present Results From Phase 3 ARISE-HF Study In Diabetic Cardiomyopathy At ACC 2024

$Applied Therapeutics(APLT.US)$ Applied Therapeutics said regulators had extended the period for reviewing its application for a rare metabolic disease treatment.
The biopharmaceutical company said Thursday that the Food and Drug Administration now has a target action date of Nov. 28 for its application, compared with the previous date of Aug. 28.
The company's application is for govorestat in the treatment of Galactosemia, a rare genetic condition that makes patients unable to metab...

🚨⚡️🚨⚡️🚨⚡️🚨 2/26/24
Watchlist.
$ZyVersa Therapeutics(ZVSA.US)$ $罗马绿色金融(ROMA.US)$ $Veru Inc(VERU.US)$ $Achilles Therapeutics(ACHL.US)$ $Gaxos.ai(GXAI.US)$ $Applied Therapeutics(APLT.US)$ $Sonder Holdings(SOND.US)$
📊⚡️📊

$Applied Therapeutics(APLT.US)$ parabolic signal 👀bought some lets go!

$辉瑞(PFE.US)$  Phase 3
$Regenxbio(RGNX.US)$  Phase 3
$Annovis Bio(ANVS.US)$  Phase 3
$Atea Pharmaceuticals(AVIR.US)$  Phase 3
$Ironwood医药(IRWD.US)$  Phase 3
$阿里拉姆制药(ALNY.US)$  Phase 3
$福泰制药(VRTX.US)$  Phase 3
$KalVista Pharmaceuticals(KALV.US)$  Phase 3
$Axsome Therapeutics(AXSM.US)$  Phase 3
$Novocure(NVCR.US)$  Phase 3
$罗氏(ADR)(RHHBY.US)$  Phase 3
$FibroGen(FGEN.US)$  Phase 3
$Applied Therapeutics(APLT.US)$  Phase 3
$阿卡迪亚(ACAD.US)$  Phase 3...

RECAP
Investors Rethink Rate Cut Bets
US equities ended Friday slightly higher, but gains weren't enough to keep major indices in the green in the first trading week of the year. The stock market ended their nine-week winning streak as investors rethink bets of aggressive interest rate cuts this year amid signs of continued strength in the labor market.
The $标普500指数(.SPX.US)$ rose 0.2% to close at 4,697.24 Friday, while the $纳斯达克综合指数(.IXIC.US)$ rose less...